On-demand education


Special series: Ms. Moreno-Fontela and Assoc. Prof. Kasivisvanathan discuss the significant transition after residency

Duration: Approx. 23 minutes

Prof. James Catto (GB) shares results of THOR-2 cohort 1 study

Duration: Approx. 7 minutes

Dr. Agarwal shares LITESPARK-013 results: Optimal dose of belzutifan is 120mg

Duration: Approx. 4 minutes

Prof. Roberto Iacovelli: Drug interruptions in mRCC IO-TKI (Avelumab and axitinib) is safe and may reduce toxicity and cost for the treatment

Duration: Approx. 6 minutes

Prof. Albiges shares LITESPARK-005 study results: Belzutifan improves PFS in pretreated mRCC patients

Duration: Approx. 5 minutes

ESMO 2023 special: Dr. Van Der Heijden talks about the phase 3 CheckMate 901 trial results

Duration: Approx. 9 minutes

ESMO 2023 special: Prof. Powles shares positive KEYNOTE-A39 trial results

Duration: Approx. 9 minutes

Special series: Artificial intelligence application for urologic cancer detection and classification

Duration: Approx. 22 minutes

Special series: 3D models for kidney cancer with caval thrombous

Duration: Approx. 12 minutes

Dr. Marra talks to Prof. Ahmed on focal therapy for low- or intermediate-risk PCa

Duration: Approx. 13 minutes

Special series: Vascular perfusion 3D models and augmented reality for RCC surgery

Duration: Approx. 19 minutes

Discussion with Prof. Badani at ERUS23 on RAPN

Duration: Approx 8 minutes

Special series: 3D models and augmented reality for prostate cancer surgery

Duration: Approx. 15 minutes

Laparoscopic v's new robotic platforms: Which surgery for which intervention?

Duration: Approx. 15 minutes

New technology for surgical training

Duration: Approx. 19 minutes

New lasers in endourology

Duration: 14 minutes